Expanding access to naloxone in the United States

References

• Warner M, Hui L, Makuc DL, Anderson RN, Miniño AM. Drug poisoning deaths in the United States, 1980–2008. NCHS data brief no 81. Hyattsville, MD: National Center for Health Statistics; 2011.
   Google Scholar
• Wheeler E, Davidson PJ, Jones S, Irwin KS. Community-based opioid overdose prevention programs providing naloxone-United States, 2010. MMWR 2012; 61:101–105.
   PubMedGoogle Scholar
• Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United Sates 2010. JAMA 2013; 309:657–659.
   PubMed Web of Science ®Google Scholar
• Heroin-related deaths in the US. Blog for the National Center for Health Statistics. http://nchstats.com/2014/02/05/heroin-related-deaths-in-the-us/[Accessed April 11 2014].
   Google Scholar
• Maryland Department of Health and Mental Hygiene. http://dhmh.maryland.gov/newsroom1/Pages/DHMH-Warns-of-Potent-and-Deadly-Drug-Combination.aspx [Accessed April 2014].
   Google Scholar
• Ogilvie L, Stanley C, Lewis L, Boyd M, Lozier M. Notes from the field: Acetyl fentanyl overdose fatalities-Rhode Island March-May 2013. MMWR 2013; 62:703–704.
   PubMed Web of Science ®Google Scholar
• Philadelphia Department of Public Health. Overdoses from tainted opioids recommendations for management. Health Advisory 2014; https://hip.phila.gov/xv/Portals/0/HIP/Health_Alerts/2014/PDPH-HAN_Advisory_2_TaintedOpioidOverdoses_012814.pdf [Accessed April 2014].
   Google Scholar
• Centers for Disease Control and Prevention. CDC Grand Rounds: Prescription drug overdoses-a U.S. epidemic. MMWR 2012; 61:10–13.
   PubMedGoogle Scholar
• Pattinson KT. Opioids and the control of respiration. Br J Anaesth 2008; 100:747–758.
   PubMed Web of Science ®Google Scholar
• Lalley PM. Opioidergic and dopaminergic modulation of respiration. Respir Physiol Neurobiol 2008; 164:160–167.
   PubMed Web of Science ®Google Scholar
• Lalley PM. Mu-opioid receptor agonist effects on medullary respiratory neurons in the cat: evidence for involvement in certain types of ventilatory disturbances. Am J Physiol Regul Integr Comp Physiol 2003; 285:R1287–1304.
   PubMed Web of Science ®Google Scholar
• Wermeling DP. A response to the opioid overdose epidemic: naloxone nasal spray. Drug Deliv Transl Res 2013; 3:63–74.
   PubMed Web of Science ®Google Scholar
• Wolfe TR, Braude DA. Intranasal medication delivery for children: a brief review and update. Pediatrics 2010; 126:532–537.
   PubMed Web of Science ®Google Scholar
• Sporer KA, Kral AH. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007; 49:172–177.
   PubMed Web of Science ®Google Scholar
• Piper TM, Stancliff S, Rudenstine S, Sherman S, Nandi V, Clear A, Galea S. Evaluation of a naloxone distribution administration program in New York City. Subst Use Misuse 2008; 43:858–870.
   PubMed Web of Science ®Google Scholar
• Enteen L, Bauer J, McLean R, Wheeler E, Huriaux E, Kral AH, Bamberger JD. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010; 87:931–941.
   PubMed Web of Science ®Google Scholar
• Dietze P, Cantwell K, Burgess S. Bystander resuscitation attempts at heroin overdose: does it improve outcomes? Drug Alochol Depend 2002; 67:213–218.
   PubMed Web of Science ®Google Scholar
• Doe-Simkins M, Quinn E, Xuan Z, Sorensen-Alawad A, Hackman H, Ozonoff A, Walley AY. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective study. BMC Public Health 2014; 14:1–11.
   PubMed Web of Science ®Google Scholar
• Loimer N, Hofmann P, Choudhry HR. Nasal administration of naloxone for detection of opiate dependence. J Psychiatr Res 1992; 26:39–43.
   PubMed Web of Science ®Google Scholar
• Loimer N, Hofmann P, Choudhry HR. Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. Int J Addict 1994; 29:819–827.
   PubMed Web of Science ®Google Scholar
• Kelly AM, Koutsogiannis Z. Intranasal naloxone for life-threatening opioid overdose. Emerg Med J 2002; 19:375.
   PubMed Web of Science ®Google Scholar
• Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, Ciccarone D, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health 2005; 82:303–311.
   PubMed Web of Science ®Google Scholar
• Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006; 25:89–96.
   PubMed Web of Science ®Google Scholar
• Tobin KA, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 2009; 20:131–136.
   PubMed Web of Science ®Google Scholar
• Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: Bystander-administered Intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 2009; 99:788–790.
   PubMed Web of Science ®Google Scholar
• Benett AS, Bell A, Tomedi L, Hulsey EG, Kral AH. Characteristics of an overdose prevention response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. J Urban Health 2011; 88:1020–1030.
   PubMed Web of Science ®Google Scholar
• Walley A, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013; 346: 1–12.
   Web of Science ®Google Scholar
• Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat 2013; 44:241–247.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Valente TW, Casanova M, Partovi SM, Mendenhall BM, Hundley JH, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy 2010; 21:186–193.
   PubMed Web of Science ®Google Scholar
• Su A, Brason FW, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: Community-based overdose prevention in Rurual North Carolina. Pain Med 2011; 12:S77–S85.
   PubMed Web of Science ®Google Scholar
• Buajordet I, Naess AC, Jacobsen D, Brørs O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Euro J Emerg Med 2004; 11:19–23.
   PubMed Web of Science ®Google Scholar
• Sporer KA. Acute heroin overdose. Ann Intern Med 1999; 130: 584–590.
   PubMed Web of Science ®Google Scholar
• Merigian KS. Cocaine-induced ventricular arrhythmias and rapid atrial fibrillation temporarily related to naloxone administration. Am J Emerg Med 1993; 11:96–7.
   PubMed Web of Science ®Google Scholar
• Osterwalder JJ. Naloxone—for intoxications with intravenous heroin and heroin mixtures—harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol 1996; 34:409–416.
   PubMed Web of Science ®Google Scholar
• Kim D, Irwin KS, Koshnood K. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health 2009; 99:402–407.
   PubMed Web of Science ®Google Scholar
• Wampler DA, Molina K, McManus J, Laws P, Manifold A. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care 2011; 15:320–324.
   PubMed Web of Science ®Google Scholar
• Vilke GM, Sloane C, Smith AM, Chan TC. Assessment for deaths in out-of-hospital heroin overdoses patients treated with naloxone who refuse transport. Acad Emerg Med 2003; 10:893–896.
   PubMed Web of Science ®Google Scholar
• Leece P, Orkin A. Opioid overdose fatality prevention (letter). JAMA 2013; 309:873–874.
   PubMed Web of Science ®Google Scholar
• Morris J. Defining the precautionary principle. In: Rethinking Risk and the Precautionary Principle. New York, NY: Butterworth-Heinemann; 2000. pp. 1–21.
   Google Scholar
• Goklany IM. From precautionary principle to risk-risk analysis. Nat Biotechnol 2002; 20:1075.
   PubMed Web of Science ®Google Scholar
• Belestky L, Rich JD, Walley AY. Opioid overdose fatality prevention (reply to letter). JAMA 2013; 309:874.
   Web of Science ®Google Scholar
• Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction 1999; 94:199–204.
   PubMed Web of Science ®Google Scholar
• Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ 2001; 322:895–896.
   PubMed Web of Science ®Google Scholar
• Tracy M, Piper TM, Ompad D, Bucciarelli A, Coffin PO, Vlahov D, Galea S. Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend 2005; 79:181–190.
   PubMed Web of Science ®Google Scholar
• Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users-are willing to administer naloxone to others. J Subst Abuse Treat 2006; 30:129–133.
   PubMed Web of Science ®Google Scholar